1 – 20 of 144
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
SERPINH1 variants and thrombotic risk among middle-aged and older adults : a population-based cohort study
(
- Contribution to journal › Letter
-
Mark
The risk for venous thromboembolism and cardiometabolic disorders in offspring from thrombosis-prone pedigrees
2024) In Journal of Thrombosis and Haemostasis(
- Contribution to journal › Article
-
Mark
Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia : data from the PedNet cohort
2024) In Journal of Thrombosis and Haemostasis(
- Contribution to journal › Article
-
Mark
Thromboembolic and bleeding risk in cardiac amyloidosis
(
- Contribution to journal › Scientific review
- 2023
-
Mark
“C1-inhibitor levels and Venous Thromboembolism : Results from a Mendelian Randomization Study”: comment from Grover et al
(
- Contribution to journal › Letter
-
Mark
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
(
- Contribution to journal › Article
-
Mark
Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders
(
- Contribution to journal › Article
-
Mark
Natural anticoagulant discovery, the gift that keeps on giving : finding FV-Short
(
- Contribution to journal › Scientific review
-
Mark
"Hereditary angioedema is associated with an increased risk of venous thromboembolism" : reply
(
- Contribution to journal › Letter
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
(
- Contribution to journal › Article
- 2022
-
Mark
Diagnosis and management of severe congenital protein C deficiency (SCPCD) : Communication from the SSC of the ISTH
(
- Contribution to journal › Article
-
Mark
The preAR2 region (1458–1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα
(
- Contribution to journal › Article
-
Mark
A hydrophobic patch (PLVIVG; 1481–1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S
(
- Contribution to journal › Article
-
Mark
Hereditary angioedema is associated with an increased risk of venous thromboembolism
(
- Contribution to journal › Letter
-
Mark
Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study
(
- Contribution to journal › Article
- 2021
-
Mark
A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D-dimer
(
- Contribution to journal › Article
-
Mark
Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme
(
- Contribution to journal › Letter
-
Mark
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
(
- Contribution to journal › Article